Dunbar, G. L., Koneru, S., Kolli, N., Sandstrom, M., Maiti, P., & Rossignol, J. (2019). Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease. Cell Transplant.
Style de citation ChicagoDunbar, Gary L., Sindhuja Koneru, Nivya Kolli, Michael Sandstrom, Panchanan Maiti, et Julien Rossignol. "Silencing of the Mutant Huntingtin Gene Through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease." Cell Transplant 2019.
Style de citation MLADunbar, Gary L., et al. "Silencing of the Mutant Huntingtin Gene Through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease." Cell Transplant 2019.